Search results
LockBit demands $25 million from London Drugs, confirming breach was actually ransomware attack
TechRadar· 2 days agoThe recent cyber-incident against Canadian pharmacy chain London Drugs was indeed a full-blown...
Bausch Health, Canada Inc. Announces Additional Public Drug Plan Listings for PrUCERIS(R)...
Digital Journal· 2 days agoLAVAL, QC / ACCESSWIRE / May 23, 2024 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced additional Canadian public < ...
IBEX011, the first Nagoya-compliant GMP iboga extract, is now available for clinical use and...
Rome Sentinel· 5 days agoToday, Terragnosis Inc., a Canadian drug development company, announced IBEX011, the first GMP...
AstraZeneca aims for $80 billion in total revenue by 2030 By Reuters
Investing.com· 4 days agoThe Anglo-Swedish drugmaker had reported total revenue of $45.81 billion last year and earlier...
Hackers release corporate data stolen from London Drugs, company says
Houston Today· 2 days agoRetailer London Drugs says cybercriminals who stole files from its corporate head office last month...
Is Tilray Stock A Buy After Biden Tweets About Pot Reclassification?
Investor's Business Daily· 4 days agoOther Canadian marijuana stocks also have mediocre or weak profit ratings as they continue to lose...
London Drugs confirms ransomware as LockBit demands $25M
The Register· 3 days agoCanadian pharmacy chain London Drugs has confirmed that ransomware thugs stole some of its corporate...
LockBit says they stole data in London Drugs ransomware attack
BleepingComputer· 4 days agoToday, the LockBit ransomware gang claimed they were behind the April cyberattack on Canadian...
Want $200 in Monthly Dividends? Invest $36,000 in These 3 Stocks
Motley Fool via Yahoo Finance· 1 day agoEnbridge: $11,000 The highest-yielding stock on this list comes from Canadian-based pipeline company...
Rakovina Therapeutics Announces $1.5 million Non-Brokered Private Placement
Digital Journal· 2 days agoThe most promising lead candidates will be further validated in the Company's laboratories at the University of British Columbia. Rakovina Therapeutics intends to advance ...